Fresenius SE & Co. (OTCMKTS:FSNUY) Issues Quarterly Earnings Results

Fresenius SE & Co. (OTCMKTS:FSNUY) announced its earnings results on Wednesday. The company reported $0.28 EPS for the quarter, Zacks reports. Fresenius SE & Co. had a net margin of 5.26% and a return on equity of 9.72%.

Fresenius SE & Co. Stock Up 0.6%

Shares of OTCMKTS:FSNUY traded up $0.10 on Wednesday, reaching $15.10. The company had a trading volume of 3,684 shares, compared to its average volume of 54,799. The firm has a market capitalization of $34.01 billion, a PE ratio of 27.45 and a beta of 0.75. The company has a current ratio of 1.26, a quick ratio of 0.99 and a debt-to-equity ratio of 0.49. Fresenius SE & Co. has a 52-week low of $9.78 and a 52-week high of $33.93. The firm’s 50 day simple moving average is $14.53 and its 200-day simple moving average is $14.39.

Wall Street Analysts Forecast Growth

Several research analysts have commented on FSNUY shares. Citigroup reaffirmed a “buy” rating on shares of Fresenius SE & Co. in a research note on Tuesday, February 3rd. Morgan Stanley reissued an “overweight” rating on shares of Fresenius SE & Co. in a research report on Monday, December 15th. Three investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock has a consensus rating of “Buy”.

About Fresenius SE & Co.

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.